...
首页> 外文期刊>Journal of Medicinal Chemistry >Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects
【24h】

Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects

机译:口服活性肽矢量允许使用大麻避免副作用的同时对抗疼痛

获取原文
获取原文并翻译 | 示例
           

摘要

The activation of cannabinoid CB1 receptors (CB1R) by Delta(9)-tetrahydrocannabinol (THC), the main component of Cannabis sativa, induces analgesia. CB1R activation, however, also causes cognitive impairment via the serotonin 5HT(2A) receptor (5HT(2A)R), a component of a CB1R-5HT(2A)R heteromer, posing a serious drawback for cannabinoid therapeutic use. We have shown that peptides reproducing CB1R transmembrane (TM) helices 5 and 6, fused to a cell-penetrating sequence (CPP), can alter the structure of the CB1R-5HT(2A)R heteromer and avert THC cognitive impairment while preserving analgesia. Here, we report the optimization of these prototypes into drug-like leads by (i) shortening the TM5, TM6, and CPP sequences, without losing the ability to disturb the CB1R-5HT(2A)R heteromer, and (ii) extensive sequence remodeling to achieve protease resistance and blood-brain barrier penetration. Our efforts have culminated in the identification of an ideal candidate for cannabis-based pain management, an orally active 16-residue peptide preserving THC-induced analgesia.
机译:大麻的主要成分δ(9)-四氢大麻酚(THC)激活大麻素CB1受体(CB1R)可诱导镇痛。然而,CB1R激活也会通过5-羟色胺5HT(2A)受体(5HT(2A)R)引起认知障碍,5HT(2A)R是CB1R-5HT(2A)R异聚体的一个组成部分,对大麻素的治疗用途构成了严重障碍。我们已经证明,与细胞穿透序列(CPP)融合的复制CB1R跨膜(TM)螺旋5和6的肽可以改变CB1R-5HT(2A)R异聚体的结构,避免THC认知损伤,同时保留镇痛作用。在这里,我们报告了通过(i)缩短TM5、TM6和CPP序列,而不丧失干扰CB1R-5HT(2A)R异聚体的能力,以及(ii)广泛的序列重塑以实现蛋白酶抗性和血脑屏障穿透,将这些原型优化为类药物先导。我们的努力最终确定了一种基于大麻的疼痛管理的理想候选者,一种口服活性16残基肽保留THC诱导的镇痛。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2021年第10期|共12页
  • 作者单位

    Univ Pompeu Fabra Dept Expt &

    Hlth Sci Barcelona 08003 Spain;

    Univ Barcelona Inst Biomed Dept Biochem &

    Mol Biomed Barcelona 08028 Spain;

    Univ Pompeu Fabra Dept Expt &

    Hlth Sci Barcelona 08003 Spain;

    Univ Pompeu Fabra Dept Expt &

    Hlth Sci Barcelona 08003 Spain;

    Univ Autonoma Barcelona Fac Med Unitat Bioestadist Lab Med Computac Bellaterra 08193 Spain;

    IMIM Hosp Mar Res Inst Integrat Pharmacol &

    Syst Neurosci Barcelona 08003 Spain;

    Univ Lisbon Fac Med Inst Med Mol P-1649028 Lisbon Portugal;

    Univ Lisbon Fac Med Inst Med Mol P-1649028 Lisbon Portugal;

    Univ Lisbon Fac Med Inst Med Mol P-1649028 Lisbon Portugal;

    Univ Barcelona Inst Biomed Dept Biochem &

    Mol Biomed Barcelona 08028 Spain;

    Univ Autonoma Barcelona Fac Med Unitat Bioestadist Lab Med Computac Bellaterra 08193 Spain;

    Univ Pompeu Fabra Dept Expt &

    Hlth Sci Barcelona 08003 Spain;

    Univ Pompeu Fabra Dept Expt &

    Hlth Sci Barcelona 08003 Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号